01 2Excella GmbH & Co. KG
02 1Olon SpA
03 1TAPI Hungary Industries Kft.
04 1Teva Pharmaceutical Works Private Limited Company
01 3Deferoxamine Mesylate
02 2Deferoxamine mesylate
01 1Israel
02 1Italy
03 2Luxembourg
04 1Blank
NDC Package Code : 46014-1003
Start Marketing Date : 2005-09-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46014-1127
Start Marketing Date : 2017-10-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0060
Start Marketing Date : 2015-01-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51846-1016
Start Marketing Date : 2022-01-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84671-1016
Start Marketing Date : 2022-01-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Deferoxamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Deferoxamine, including repackagers and relabelers. The FDA regulates Deferoxamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Deferoxamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Deferoxamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Deferoxamine supplier is an individual or a company that provides Deferoxamine active pharmaceutical ingredient (API) or Deferoxamine finished formulations upon request. The Deferoxamine suppliers may include Deferoxamine API manufacturers, exporters, distributors and traders.
click here to find a list of Deferoxamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Deferoxamine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Deferoxamine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Deferoxamine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Deferoxamine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Deferoxamine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Deferoxamine suppliers with NDC on PharmaCompass.
We have 3 companies offering Deferoxamine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
